Company intelligence / Profile preview

Memory Treatment Centers

Bonita Springs, Florida, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

Memory Treatment Centers is a healthcare provider specializing in early diagnosis and treatment of Alzheimer's disease and related dementias. They were among the first in the U.S. to offer Leqembi (lecanemab) and Kisunla (donanemab)—two FDA-approved anti-amyloid monoclonal antibody therapies shown to modestly slow progression of cognitive decline in early-stage Alzheimer's. The center participates in real-world implementation of these therapies and focuses on comprehensive, individualized care[1][2][3][5][7][8].

Therapeutic areas: ImmunologyNeurology
Modalities: BiologicSmall moleculeNon-pharmacological therapy
Industry: Non-Academic Healthcare

Partnerships

Pure Infusion SuitesOxford Brain Diagnostics[4]Craniometrix (GUIDE caregiver support program)[8]

Beyond the preview

Go deeper on Memory Treatment Centers.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Memory Treatment Centers.

Explore the full profile